[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2078055T3 - Prostaglandinas. - Google Patents

Prostaglandinas.

Info

Publication number
ES2078055T3
ES2078055T3 ES92915265T ES92915265T ES2078055T3 ES 2078055 T3 ES2078055 T3 ES 2078055T3 ES 92915265 T ES92915265 T ES 92915265T ES 92915265 T ES92915265 T ES 92915265T ES 2078055 T3 ES2078055 T3 ES 2078055T3
Authority
ES
Spain
Prior art keywords
formula
compound
hexahidro
hidroxi
fenil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92915265T
Other languages
English (en)
Inventor
Jozsef Ivanics
Tibor Szab
Istvan Hermecz
Gyula Dalmadi
Jozsefne Ivanics
Gaborne Kovacs
Resul Bahram
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Pfizer Health AB
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt, Pharmacia AB filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Application granted granted Critical
Publication of ES2078055T3 publication Critical patent/ES2078055T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Emergency Lowering Means (AREA)

Abstract

LA INVENCION SE REFIERE A UN NUEVO PROCESO PARA LA PREPARACION DE UN ESTER DE 13, 14-DIHIDRO-15(R)-17-FENIL-18, 19, 10-TRINORPGF2(ALFA) ISOPROPIL DE LA FORMULA (I), EN DONDE R REPRESENTA UN GRUPO DE ALQUIL O FENIL C1-C7 SATURADO O INSATURADO, RECTO, RAMIFICADO O CICLICO. EL PROCESO DE LA INVENCION COMPRENDE LA REDUCCION DEL GRUPO OXO DE LA CADENA LATERAL DEL COMPUESTO DE LA FORMULA (VII), TRANSFORMANDO EL 3,3A,4,5,6,6A-HEXAHIDRO-2-OXO-4-[5''-FENIL-3''(R)HIDROXIPENT-1''-ENIL]-5-(4''-FENILBENZOXILOXIDO)-2H-CICLOPENTA[B] FURAN OBTENIDO DE LA FORMULA (VI) MEDIANTE SU HIDROGENACION EN 3,3A, 4,5,6,6A-HEXAHIDRO-2-OXO-4-[5''-FENIL-3''(R)-HIDROXI-1''PENTIL]-5-(4''-FENILBENZILOXIDO)-2H-CICLOPENTA[B]FURAN OBTENIDA DE LA FORMULA (V) REDUCIENDO EL COMPUESTO DE LA FORMULA (V) EN 3,3A,4,5,6,6A-HEXAHIDRO-2-HIDROXI-4-[5''-FENIL-3''(R)-HIDROXI-1''PENTIL]-5-(4''-FENILBENZILOXI)-2H-CICLOPENTA[B]FURAN DE LA FORMULA (IV), SEPARANDO EL GRUPO PROTECTOR DE LA FORMULA (IV) PARA OBTENER 3,3A,4,5,6,6A,HEXAHIDRO-2,5-DIHIUDROXI-4-[5''-FENIL-3''(R)HIDROXI-1''-PENTIL]-2H-CICLOPENTA[B]FURAN DE LA FORMULA (III) Y ENTONCES TRANSFORAMANDO EL COMPUESTO DE LA FORMULA (III) OBTENIDO EN 13,14-DIHIDRO-15(R)-17-FENIL-18, 19, 20-TRINOR-PGF2(ALFA) DE LA FORMULA (II) USANDO ALURO DE 4-CARBOXIBUTIL-TRIFENILFOSFONIO Y FINALMENTE, TRANSFORMANDO EL COMPUESTO DE LA FORMULA (II) CON UN COMPUESTO DE LA FORMULA GENERAL R-X O, X ES SULFATO DE HALOGENO, MESIL, TOSIL O CUALQUIER GRUPO ADECUADO PARA LOS ESTERES DE 13,14DIHIDRO.15(R)-17-FENIL-18, 19, 20-TRINOR-PGF2(ALFA) DE LA FORMULA (I).
ES92915265T 1991-06-24 1992-06-19 Prostaglandinas. Expired - Lifetime ES2078055T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU912092A HU212570B (en) 1991-06-24 1991-06-24 Process for producing 13,14-dihydro-15(r)-17-phenyl-18,19,20-trinor-pgf2alfa-isopropylester

Publications (1)

Publication Number Publication Date
ES2078055T3 true ES2078055T3 (es) 1995-12-01

Family

ID=10957725

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92915265T Expired - Lifetime ES2078055T3 (es) 1991-06-24 1992-06-19 Prostaglandinas.

Country Status (23)

Country Link
US (1) US5466833A (es)
EP (1) EP0544899B1 (es)
JP (1) JP2635213B2 (es)
KR (1) KR0163022B1 (es)
CN (1) CN1035764C (es)
AT (1) ATE127450T1 (es)
AU (1) AU656994B2 (es)
BG (1) BG61261B1 (es)
CZ (1) CZ287168B6 (es)
DE (1) DE69204627T2 (es)
DK (1) DK0544899T3 (es)
ES (1) ES2078055T3 (es)
FI (1) FI104895B (es)
GR (1) GR3017874T3 (es)
HU (1) HU212570B (es)
IE (1) IE71645B1 (es)
IL (1) IL102280A (es)
PL (1) PL170728B1 (es)
RO (1) RO117323B1 (es)
RU (1) RU2099325C1 (es)
TW (1) TW310321B (es)
UA (1) UA39864C2 (es)
WO (1) WO1993000329A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510383A (en) † 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
US6225348B1 (en) 1998-08-20 2001-05-01 Alfred W. Paulsen Method of treating macular degeneration with a prostaglandin derivative
IL143477A (en) 2001-05-31 2009-07-20 Finetech Pharmaceutical Ltd Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
IL134241A (en) * 2000-01-27 2006-06-11 Finetech Pharmaceutical Ltd Process for the preparation of latanoprost
GB0112699D0 (en) * 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
US20110065129A1 (en) * 2001-07-27 2011-03-17 Lowe Derek B Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
US20050119262A1 (en) * 2003-08-21 2005-06-02 Pharmacia Corporation Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
ITRM20050231A1 (it) * 2005-05-13 2006-11-14 Technopharma Sa Procedimento per la sintesi di derivati delle prostaglandine f.
US7511168B2 (en) 2006-01-18 2009-03-31 Shih-Yi Wei Processes and intermediates for the preparations of prostaglandins
US8546114B2 (en) 2006-01-18 2013-10-01 Chirogate International Inc. Processes for the preparation of optically active cyclopentenones and cyclopentenones prepared therefrom
JP2008037782A (ja) * 2006-08-04 2008-02-21 Daiichi Fine Chemical Co Ltd プロスタグランジン誘導体の製造方法
US7642370B2 (en) 2006-08-07 2010-01-05 Daiichi Fine Chemical Co., Ltd. Method for preparing prostaglandin derivative
IT1392492B1 (it) 2008-12-24 2012-03-09 Ind Chimica Srl Processo per la purificazione del latanoprost, analogo sintetico della prostaglandina pgf2alfa.
DK2523669T3 (en) * 2010-01-11 2017-02-06 Inotek Pharmaceuticals Corp COMBINATION, KIT AND PROCEDURE TO REDUCE INTRAOCULAR PRESSURE
SG184221A1 (en) 2010-03-26 2012-10-30 Inotek Pharmaceuticals Corp Method of reducing intraocular pressure in humans using n6 -cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof
EP2495235B1 (en) 2011-03-04 2015-08-05 Newchem S.p.A. Process for the synthesis of prostaglandins and intermediates thereof
MX341839B (es) * 2011-06-02 2016-09-05 Chinoin Zrt Nuevos procesos para la preparacion de las amidas de prostaglandina.
HU231203B1 (hu) * 2011-12-21 2021-10-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás travoprost előállítására
ES2637332T3 (es) 2012-01-26 2017-10-11 Inotek Pharmaceuticals Corporation Polimorfos anhidros de nitrato de (2R,3S,4R,5R)-5-(6-(ciclopentilamino)-9H-purin-9-il)-3,4-dihidroxitetrahidrofuran-2-il)}metilo y procedimientos de preparación del mismo
HU230744B1 (hu) * 2012-11-30 2018-01-29 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás travoprost előállítására
EA201591433A1 (ru) 2013-03-15 2015-12-30 Инотек Фармасьютикалс Корпорейшн Офтальмологические составы
HU231214B1 (hu) * 2014-03-13 2021-11-29 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás nagytisztaságú prosztaglandinok előállítására

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786251A (fr) * 1971-07-14 1973-01-15 Ici Ltd Nouveaux derives du cyclopentane
US3971826A (en) * 1972-07-13 1976-07-27 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
ES2062102T5 (es) * 1988-09-06 2004-12-01 Pharmacia Ab Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.

Also Published As

Publication number Publication date
HUT62561A (en) 1993-05-28
AU656994B2 (en) 1995-02-23
DK0544899T3 (da) 1995-10-23
RU2099325C1 (ru) 1997-12-20
KR0163022B1 (ko) 1999-01-15
CN1035764C (zh) 1997-09-03
CZ287168B6 (en) 2000-10-11
AU2262992A (en) 1993-01-25
PL170728B1 (pl) 1997-01-31
HU212570B (en) 1996-08-29
RO117323B1 (ro) 2002-01-30
CN1072408A (zh) 1993-05-26
BG97471A (bg) 1994-03-24
BG61261B1 (en) 1997-04-30
FI930773A (fi) 1993-02-22
IE922026A1 (en) 1992-12-30
JPH06500804A (ja) 1994-01-27
GR3017874T3 (en) 1996-01-31
PL298127A1 (en) 1994-01-24
CZ27193A3 (en) 1993-10-13
JP2635213B2 (ja) 1997-07-30
ATE127450T1 (de) 1995-09-15
DE69204627D1 (de) 1995-10-12
EP0544899A1 (en) 1993-06-09
TW310321B (es) 1997-07-11
IL102280A (en) 1998-02-08
IE71645B1 (en) 1997-02-26
UA39864C2 (uk) 2001-07-16
EP0544899B1 (en) 1995-09-06
DE69204627T2 (de) 1996-05-02
FI930773A0 (fi) 1993-02-22
FI104895B (fi) 2000-04-28
WO1993000329A1 (en) 1993-01-07
HU912092D0 (en) 1991-12-30
US5466833A (en) 1995-11-14

Similar Documents

Publication Publication Date Title
ES2078055T3 (es) Prostaglandinas.
DK618588A (da) Benzocyclohepten-derivater
DK0403351T3 (da) Fremgangsmåde til fremstilling af ascorbinsyre
ES533338A0 (es) Derivados de la 2-pirimidinil-1-piperazina
ES2149734T3 (es) Metodo para la preparacion de citalopram.
ES2071621T3 (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
FR2361353A1 (fr) Derives de cyclohexane utiles comme cristaux liquides
ES2066140T3 (es) Derivados de acidos 7-ceto- y 7-hidroxi-androsta-3,5-dieno-3-carboxilicos.
OA09016A (fr) Produits cathartiques.
ATE144238T1 (de) Verwendung von pilzmyzel als bodenhilfsstoff
DE69111534D1 (de) Verfahren zur Herstellung von Alpha-Olefin durch Ethenolyse.
ATE60768T1 (de) Verfahren zur herstellung von thienylaethylaminen, und mittels des verfahrens hergestellte dithienylaethylamine.
ITTO920532A0 (it) Procedimento per la preparazione di delta lattoni saturi per bioidro-genazione dei corrispondenti composti insaturi naturali mediante microrganismi.
MX9303966A (es) Derivados de benzotiazepina y benzoxazepina.
ATE62243T1 (de) Verfahren zur herstellung eines optisch aktiven lactons und neue zwischenprodukte in diesem verfahren.
ES509782A0 (es) Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol y etanodiol.
ATE66920T1 (de) Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten.
EP0414903A4 (en) New thioproline derivative
ES2095985T3 (es) Analogos de fosfato de inositol como sustancias antagonistas del calcio.
ES2055223T3 (es) Compuestos ciclicos y procedimiento para su preparacion.
JPS5424888A (en) Novel 7alpha-methoxycephalosporins and their preparation
ATE123488T1 (de) Verfahren zur herstellung von benzolsulfonamiden.
SE7706083L (sv) Bicykliska laktondiolderivat jemte sett for deras framstellning
ATE179167T1 (de) Antivirale analoge von difluorostaton
ES2141384T3 (es) Fabricacion de levobupivacaina y analogos de la misma a partir de l-lisina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 544899

Country of ref document: ES